Randomized, Double-Blind, Multi-Center, Phase 3 Trial to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/Hydrochlorothiazide Combination in Comparison With Telmisartan/Amlodipine Combination for Essential Hypertension Patients Not Controlled by Telmisartan/Amlodipine Combination
Phase of Trial: Phase III
Latest Information Update: 29 Nov 2016
At a glance
- Drugs Amlodipine/telmisartan/hydrochlorothiazide (Primary) ; Amlodipine/telmisartan
- Indications Essential hypertension
- Focus Registrational; Therapeutic Use
- Sponsors Ildong Pharmaceutical
- 23 Nov 2016 Status changed from recruiting to completed.
- 28 Apr 2016 The protocol has been amended with the change in the dosage of Hydrochlorothiazide from 12.5 to 25mg 1 Tab.QD
- 28 Apr 2016 Planned number of patients changed from 150 to 300.